The Report China In Vitro Diagnostics (IVD) Market, Forecast & Companies Analysis provides information on pricing, market analysis, shares, forecast, and company profiles for key industry participants. - MarketResearchReports.biz

Albany, NY -- (SBWire) -- 12/05/2014 --China is gradually becoming a competitive force and evolving into the world's fastest growing market for In Vitro Diagnostics (IVD) products. By 2018 Chinese IVD market with Billion US$ is expected to be twice more than from its current market size in 2013. Immunoassay has the highest market share compared to all other segments of In Vitro Diagnostics. Clinical Chemistry is in the 2nd position, but its market share is declining year on year, however its market is growing year on year. Molecular Diagnostics holds the 3rd position and its market share is also rising year on year. Roche holds the highest market share in China In Vitro Diagnostics market.

View Full Report at http://www.marketresearchreports.biz/analysis/235012

This is 3rd edition report on In Vitro Diagnostics sector by Renub Research. Report titled "China In Vitro Diagnostics (IVD) Market, Forecast & Companies Analysis" provides a comprehensive assessment of the fast–evolving, high–growth IVD Market in China. This 77 page report with 34 Figures studies the China IVD market from 4 view points:

* Market and Forecast
* Segment Wise Market & Forecast
* Development Environment & Regulatory Status in China IVD market
* Company Wise IVD Sales & Forecast

China IVD Market – Application Segment Analysis (2007 – 2018)

* Clinical Chemistry Market
* Immunoassay Market
* Hematology Market
* Coagulation Market
* Microbiology Market
* Molecular Testing Market
* Self Monitoring of Blood Glucose (SMBG) Market
* Point of Care Testing (POCT) Market

Download Detail Report With Complete TOC at http://www.marketresearchreports.biz/sample/sample/235012

China IVD – Company Wise Sales Analysis (2010 – 2018)

* Roche Diagnostic
* Sysmex Corporation
* Mindray Medical International Limited
* Shanghai Kehua Bio–Engineering Co. Ltd.
* Others

Explore All Latest Published Reports By Renub Research at http://www.marketresearchreports.biz/publisher/31

Profiles of Private Clinical Labs and Diagnostic Services Companies in China

* Zhejiang Di'an Diagnostics Technology Co., Ltd
* ADICON Clinical Laboratories
* Guangzhou Kingmed Diagnostics Center Co. Ltd.
* Kindstar Global (Privately held)
* BGI–Shenzhen (Privately held)
* OriGene Technologies (Privately held)

Related Reports

Molecular Diagnostics Partnering Terms and Agreements

View Full Report at http://www.marketresearchreports.biz/analysis/225407

The Molecular Diagnostics Partnering Terms and Agreements report provides a detailed understanding and analysis of how and why companies enter molecular diagnostics partnering deals. These deals tend to be multicomponent, starting with collaborative R&D, and commercialization of outcomes.

Download Detail Report With Complete TOC at http://www.marketresearchreports.biz/sample/sample/225407

This report provides details of the latest molecular diagnostics agreements announced in the healthcare sectors.

Understanding the flexibility of a prospective partner's negotiated deals terms provides critical insight into the negotiation process in terms of what you can expect to achieve during the negotiation of terms. Whilst many smaller companies will be seeking details of the payments clauses, the devil is in the detail in terms of how payments are triggered - contract documents provide this insight where press releases and databases do not.

China Diagnostic Reagent Industry Report, 2013-2016

View Full Report at http://www.marketresearchreports.biz/analysis/213590

With the accelerated aging of the Chinese population, the increase of personal health expenditure as well as the improved medical care facilities and government health care system, China diagnostic reagent industry has been developing quickly, especially in vitro diagnostic reagents occupy over 90%. In 2013, Chinese in vitro diagnostics market size reached RMB22.98 billion, of which RMB16.61 billion came from in vitro diagnostic reagents.

Download Detail Report With Complete TOC at http://www.marketresearchreports.biz/sample/sample/213590

Chinese in vitro diagnostic reagent market consists of biochemical diagnostic reagents, immunodiagnostic reagents and molecular diagnostic reagents. Among them, the immune reagents and biochemical reagents account for a relatively higher combined proportion, such as around 65% in 2013.

About MarketResearchReports.biz
MarketResearchReports.biz is the most comprehensive collection of market research reports. MarketResearchReports.Biz services are specially designed to save time and money for our clients. We are a one stop solution for all your research needs, our main offerings are syndicated research reports, custom research, subscription access and consulting services. We serve all sizes and types of companies spanning across various industries.

Browse Blog at https://chinaindustryanalysis.wordpress.com/

Contact Us

Office: State Tower
90 Sate Street, Suite 700
Albany, NY 12207
United States
Tel: +1-518-618-1030
USA: Canada Toll Free: 866-997-4948
Website: http://www.marketresearchreports.biz/
E: sales@marketresearchreports.biz